SC Filed 2021-08-18 Event — SEC 0001104659-21-107408 →

RA CAPITAL MANAGEMENT, L.P. → Wave Life Sciences Ltd. WVE

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

5 transactions

0 buys · 4 sales · 1 awards/exercises

Issuer Cluster

10 13D/G filings on this issuer

9 other filings besides this one

Filer Track Record

83 filings by this filer

82 other filings in the data moat

Short Interest · settle 2026-08-14

DTC 4.39

16,200,874 shares short · -1.2% vs prior

Institutional Consensus · 2026-06-30

Held by elite portfolio managers

1 holder · $1K

Duquesne Family Office

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-08-12	Rawcliffe Adrian	director	Sale	12,700	$5.29	$67K
2026-08-11	Wagner Heidi L	director	Option exercise	7,000	$5.97	$42K
2026-08-11	Wagner Heidi L	director	Sale	7,000	$6.01	$42K
2026-08-11	TAKANASHI KEN	director	Sale	3,864	$6.01	$23K
2026-08-11	Tan Aik Na	director	Sale	432	$6.01	$3K

Other 13D/G Filings on Wave Life Sciences Ltd.

Filed	Form	Filer	Stake	Shares
2026-08-11	SCHEDULE 13D/A	RA CAPITAL MANAGEMENT, L.P.	—	34,314,406	view →
2024-10-01	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →
2022-08-12	SC	Shin Nippon Biomedical Laboratories, Ltd.	—	—	view →
2022-07-20	SC	Kagoshima Shinsangyo Sousei Investment Limited Partnership	—	—	view →
2021-11-12	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →
2019-02-20	SC	Shin Nippon Biomedical Laboratories, Ltd.	—	—	view →
2019-01-28	SC	RA CAPITAL MANAGEMENT, LLC	—	—	view →
2018-04-26	SC	Shin Nippon Biomedical Laboratories, Ltd.	—	—	view →
2018-03-22	SC	Kagoshima Shinsangyo Sousei Investment Limited Partnership	—	—	view →

Other Filings by RA CAPITAL MANAGEMENT, L.P.

Filed	Form	Issuer	Stake	Shares
2026-09-03	SCHEDULE 13G	JATT III Acquisition Corp	—	—	view →
2026-08-17	SCHEDULE 13G	Latigo Biotherapeutics, Inc.	—	—	view →
2026-08-14	SCHEDULE 13D/A	SEPTERNA, INC.	—	5,525,324	view →
2026-08-11	SCHEDULE 13D/A	Wave Life Sciences, Inc.	—	34,314,406	view →
2026-08-10	SCHEDULE 13D/A	SAB Biotherapeutics, Inc.	—	9,609,852	view →
2026-07-23	SCHEDULE 13D/A	ARTIVA BIOTHERAPEUTICS, INC.	—	18,415,956	view →
2026-07-22	SCHEDULE 13D/A	Freenome, Inc.	—	15,367,270	view →
2026-07-21	SCHEDULE 13D/A	VOR BIOPHARMA INC.	—	12,937,855	view →
2026-07-20	SCHEDULE 13G	Agenus Inc.	—	—	view →
2026-07-07	SCHEDULE 13D/A	Climb Bio, Inc. CLYM	33.00%	23,249,186	view →
2026-07-02	SCHEDULE 13D/A	WEREWOLF THERAPEUTICS, INC. HOWL	4.10%	1,985,541	view →
2026-06-26	SCHEDULE 13D/A	WEREWOLF THERAPEUTICS, INC. HOWL	6.00%	2,915,742	view →
2026-06-24	SCHEDULE 13D/A	SOLID BIOSCIENCES INC. SLDB	—	12,036,126	view →
2026-06-22	SCHEDULE 13D/A	WEREWOLF THERAPEUTICS, INC. HOWL	—	3,654,307	view →
2026-06-18	SCHEDULE 13D	Parabilis Medicines, Inc. PBLS	23.80%	28,933,371	view →
2026-06-15	SCHEDULE 13D/A	ARTIVA BIOTHERAPEUTICS, INC. ARTV	36.60%	17,811,623	view →
2026-06-15	SCHEDULE 13D/A	WEREWOLF THERAPEUTICS, INC. HOWL	—	5,138,703	view →
2026-06-03	SCHEDULE 13G	Editas Medicine, Inc. EDIT	—	—	view →
2026-05-21	SCHEDULE 13G	Sana Biotechnology, Inc. SANA	—	—	view →
2026-05-14	SCHEDULE 13D/A	WEREWOLF THERAPEUTICS, INC. HOWL	—	6,116,140	view →

Showing 20 of 82

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →